BackORIX JREIT Overview

ORIX JREIT EBIT

Latest ebit for ORXJF: $55B, below the sector sector average of $2.6T.

Get informed when a big investor buys or sells

+ Follow

Quarterly EBIT

$16.28B
↑ 33.01% YoY

As of Feb 28, 2026

Annual EBIT (TTM)

$55.31B
↑ 11.95% YoY

Trailing 12 months ending Feb 28, 2026

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

ORIX JREIT (ORXJF) FAQ

The latest EBIT for ORXJF is $55B as of February 2026. That compares with $49B in the prior-year period — up 12.0% year over year. That is below the sector sector average of $2.6T. Investors often review this figure alongside ORIX JREIT's historical trend and sector peers before judging valuation or financial health.

Over the past year, ORXJF's EBIT moved from $49B to $55B — a 12.0% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in ORIX JREIT's operating scale or balance-sheet position.

Against its sector companies, ORXJF currently prints $55B for EBIT, while the sector average sits near $2.6T. That is roughly 97.9% below the sector mean. Large gaps often invite a closer look at ORIX JREIT's growth, margins, and balance sheet.

A EBIT figure of $55B for ORXJF is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The sector average is about $2.6T. Explore the charts below for those layers of context.

After noting ORXJF's EBIT ($55B), review year-over-year change from $49B, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.